Managing Haemophilia for Life: 5th Haemophilia Global Summit.

about

Extravascular FIX and coagulation Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.

P2860

Q28079369-5C337545-AC52-4DD1-83E0-9F79B4E388DD Q41430592-21593C78-4A30-44B3-B7E9-34B59F9AB475

P2860

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

Item

http://www.wikidata.org/entity/Q45879098

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@en

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@nl

type

Item

label

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@en

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@nl

prefLabel

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@en

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@nl

P1476

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

@en

P2093

Brian O'Mahony

http://www.w3.org/2001/XMLSchema#string

Cedric Hermans

http://www.w3.org/2001/XMLSchema#string

E Carlos Rodríguez-Merchán

http://www.w3.org/2001/XMLSchema#string

Gerry Dolan

http://www.w3.org/2001/XMLSchema#string

Ian Jennings

http://www.w3.org/2001/XMLSchema#string

Sébastien Lobet

http://www.w3.org/2001/XMLSchema#string

P2860

The up and down bobbing of human walking: a compromise between muscle work and efficiency

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.

Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring

Measurement of factor VIII activity of B-domain deleted recombinant factor VIII.

Haemophilia care in the developing world: benchmarking for excellence.

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.

Assaying the circulating factor VIII activity in hemophilia A patients treated with recombinant factor VIII products.

Radiological assessment of haemophilic arthropathy with emphasis on MRI findings.

P304

1-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12617

http://www.w3.org/2001/XMLSchema#string

P478

95 Suppl 78

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Di Minno

Víctor Jiménez-Yuste

J Windyga

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281635692

http://www.w3.org/2001/XMLSchema#string

P698

26350039

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

about

P2860

P2860

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921